Daubert Hearings for Zantac Cancer Lawsuits To Be Held in September 2022
A federal judge has scheduled hearings over Zantac cancer lawsuit Daubert motions for September.
Tag Archives: NDMA
-
-
Valsartan Settlement Masters Appointed To Advance Negotiations in MDL
Two former district judges have been appointed as valsartan settlement special masters to help bring about a resolution to the litigation.
-
Extended Use of Valsartan and Other Angiotensin-Receptor Blockers May Increase Cancer Risk: Study
Valsartan and similar hypertension drugs may carry an increased risk of cancer with long-term use, according to the findings of a new study.
-
Zantac MDL Judge Indicates “Time Has Come” To Finalize Registry Data for Pending Claims
A federal judge is calling on parties in Zantac cancer litigation to finalize a registry of potential plaintiffs and their information as the lawsuits enter the latter stages of pretrial…
-
Zantac MDL Moving Forward With Expert Support For Causing Bladder, Esophageal, Gastric, Liver and Pancreatic Cancers
Plaintiffs have identified five types of cancer which will be pursued in federal Zantac lawsuits, including bladder cancer, esophageal cancer, gastric cancer, liver cancer and pancreatic cancer.
-
Generic Metformin Recall Issued Over NDMA Contamination
Dozens of batches of generic metformin are being recalled due to the presence of NDMA; a cancer-causing chemical byproduct which has led to numerous drug recalls in recent years.
-
Sanctions Granted Against Valsartan Manufacturer for Discovery Abuses
A Special Master involved in valsartan litigation has determined Zhejiang Huahei Pharmacticals, the manufacturer of the active ingredient, should pay sanctions for failing to provide appropriate answers to some questions…
-
Zantac Science Day Presentations About Heartburn Drug Cancer Risks Underway in MDL
Parties involved in litigation over the cancer risks of the heartburn drug Zantac will take part in a Zantac Science Day today and tomorrow in federal court.
-
Class Action Lawsuit Filed Over Presence of Toxic Chemicals in Chantix
A class action lawsuit claims the presence of potentially cancer-causing chemicals made Chantix an illegal and unadulterated drug which was never approved by the FDA.
-
Zantac Cancer Lawsuits To Be Selected For Bellwether Trial Pool
A pool of 200 randomly selected Zantac cancer claims will form the initial discovery pool, from which the first bellwether cases will be selected.